A New Edition of The New England Journal of Medicine Is Now Available

March 12, 2021

The New England Journal of Medicine (vol. 382, no. 16, 2020) is available online by subscription only.

Articles include:

  • “A Strategy for Improving U.S. Health Care Delivery — Conducting More Randomized, Controlled Trials” by A. Finkelstein
  • “Evidence from Pragmatic Trials during Routine Care — Slouching toward a Learning Health System” by G.E. Simon, R. Platt, and A.F. Hernandez
  • “One in Four — The Importance of Comprehensive Fertility Benefits for the Medical Workforce” by E.C. Kaye
  • “Not a Perfect Storm — Covid-19 and the Importance of Language” by A.M. Brandt and A. Botelho
  • “Covid-19 and the Stiff Upper Lip — The Pandemic Response in the United Kingdom” by D.J. Hunter
  • “A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia” by K.S. Koblan, et al.
  • “Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol” by K.K. Ray, et al.
  • “Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia” by F.J. Raal, et al.

 

Posted by

Posted in Clinical / Medical, Covid-19, Global Bioethics, Healthcare, Journal Articles, Mental Health, Neuroethics, Pharma, Public Health, Public Policy, Reproductive Ethics, Research Ethics

Ad